Cite
HARVARD Citation
Kvien, T. et al. (n.d.). SAT0070 Baricitinib versus adalimumab in patients with active rheumatoid arthritis: analysis of patients achieving a moderate eular response at week 4. Annals of the rheumatic diseases. pp. 794-795. [Online].